Tacrolimus confers lower acute rejection rates and better renal allograft survival compared to cyclosporine
Author:
Publisher
Baishideng Publishing Group Inc.
Reference15 articles.
1. Calcineurin‐inhibitors in renal transplantation. Too precious to be abandoned
2. Chronic rejection and graft half-life: five-year follow-up of the european tacrolimus multicenter renal study
3. Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
4. Renal Graft Survival and Calcineurin Inhibitor
5. A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years1
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Review of two immunosuppressants: tacrolimus and cyclosporine;Journal of the Korean Association of Oral and Maxillofacial Surgeons;2023-12-31
2. CYP3A5*3 and CYP3A4*22 Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach;Pharmaceutics;2023-11-29
3. Diabetes is a significant and independent predictor for tacrolimus immediate release and LCP‐tacrolimus conversion ratios;Clinical Transplantation;2023-02-23
4. Redox-Responsive Hyaluronic Acid–Tacrolimus Conjugate: Synthesis, Characterization, and In Vitro Immunosuppressive Activity;ACS Applied Bio Materials;2023-01-16
5. Cost-saving induction immunosuppressive protocol in mild-to-moderate immunological risk renal transplantation;Journal of The Egyptian Society of Nephrology and Transplantation;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3